JOINN Laboratories

JOINN Laboratories is the largest public non-clinical Contract Research Organization (CRO) in China and a global leader in drug safety evaluation. Founded in 1995, the company provides a comprehensive range of end-to-end preclinical drug discovery and development services, including toxicology, pharmacology, efficacy studies, and drug metabolism/pharmacokinetics (DMPK). JOINN operates state-of-the-art facilities across China (Beijing, Suzhou, Chongqing, Guangzhou) and has expanded into the United States through the acquisition of Biomere (Richmond, CA, and Worcester, MA). The company is dual-listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange, serving a diverse client base of over 30 global pharmaceutical and biotechnology companies. It is recognized for its high regulatory standards, holding GLP certifications from the US FDA, China's NMPA, OECD, Japan's PMDA, and Korea's MFDS.